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INTRODUCTION
Traditional herbal medicines have been used for the pre-
vention and treatment for diabetes mellitus, which is claimed
to be achieved through integrated effects from multiple ingre-
dients (1). Recently, KIOM-79, a mixture of ethanol extracts
from four herbs (parched Puerariae radix, gingered Magnoli-
ae cortex, Glycyrrhizae radix and Euphorbiae radix) was devel-
oped based on the basic known function of each herb in treat-
ing diabetes (2-5). Recent studies demonstrate beneficial
effects of KIOM-79 on diabetic Goto-Gakizaki rats (6). In
the murine macrophages, the inhibition of NF-κ B signal-
ing by KIOM-79 was observed, suggesting an anti-inflam-
matory action of KIOM-79 (7). Also, KIOM-79 inhibits
VEGF expression induced by high glucose or by advanced
glycosylation end-products (AGEs) in human retinal pig-
ment epithelial cells (8). 
In the process of therapeutic drug development, promis-
ing candidate compounds are frequently dropped out due to
their potential risk of cardiac arrhythmia caused by, for exam-
ple, K+ channel inhibition or incomplete inactivation of Na+
channels (9). Such undesirable effects slow the cardiac repo-
larization phase, which frequently induces early after-depo-
larization (EAD). The changes in action potential duration
(APD) are usually assessed in terms of the QT interval in the
electrocardiogram (ECG). People with inherited mutations
of various cardiac ion channels or treated drugs affecting car-
diac ion channels show the prolongation of QT interval (long-
QT syndrome, LQTS). In severe cases, the afterdepolariza-
tion induced by LQTS can trigger fatal arrhythmia, torsade
de pointes. Although the life-threatening QT prolongation by
medical drugs is relatively rare, such risk is obviously unac-
ceptable for novel drug development (9-11). In this respect,
traditional herbal medicine should be of no exception for the
screening of drug-induced cardiac arrhythmia.
The action potential (AP) of cardiac ventricular myocytes
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Effects of Mixed Herbal Extracts from Parched Puerariae Radix, 
Gingered Magnoliae Cortex, Glycyrrhizae Radix and Euphorbiae Radix
(KIOM-79) on Cardiac Ion Channels and Action Potentials
KIOM-79, a mixture of ethanol extracts from four herbs (parched Puerariae radix,
gingered Magnoliae cortex, Glycyrrhizae radix and Euphorbiae radix), has been
developed for the potential therapeutic application to diabetic symptoms. Because
screening of unexpected cardiac arrhythmia is compulsory for the new drug devel-
opment, we investigated the effects of KIOM-79 on the action potential (AP) and
various ion channel currents in cardiac myocytes. KIOM-79 decreased the upstroke
velocity (Vmax) and plateau potential while slightly increased the duration of action
potential (APD). Consistent with the decreased Vmax and plateau potential, the peak
amplitude of Na
+ current (INa) and Ca
2+ current (ICa,L) were decreased by KIOM-79.
KIOM-79 showed dual effects on hERG K
+ current; increase of depolarization phase
current (Idepol) and decreased tail current at repolarization phase (Itail). The increase
of APD was suspected due to the decreased Itail. In computer simulation, the change
of cardiac action potential could be well simulated based on the effects of KIOM-
79 on various membrane currents. As a whole, the influence of KIOM-79 on cardiac
ion channels are minor at concentrations effective for the diabetic models (0.1-10 μ g/
mL). The results suggest safety in terms of the risk of cardiac arrhythmia. Also, our
study demonstrates the usefulness of the cardiac computer simulation in screening
drug-induced long-QT syndrome.
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Accepted : 25 July 2008is divided into five phases. In phase 0, Na+ current activation
rapidly depolarizes the membrane. The subsequent phase 1
of slight repolarization is followed by a plateau depolarization
(phase 2). The phase 2 is due to suppression of inward recti-
fier as well as the delayed activation of K+ currents like IKr
and IKs. The termination of phase 2 is caused by the phase 3
repolarization to resting membrane potential, phase 4 (12-14). 
The human ether-a$-go-go-related gene (hERG) encodes
the potassium channel that provides the major repolarizing
current early in phase 3 of the cardiac action potential. Inher-
ited LQTS are caused by loss-of-function mutations in several
cardiac K+ channels like hERG and KCNQ1/mink (LQT1,
LQT2), or disrupted fast inactivation of Na+ channel, SCN5A
(LQT3) (10, 11, 14). In clinical practice, the drug-induced
QT prolongation is most commonly caused by direct block-
age of hERG channels (9, 11, 14). An incomplete inactiva-
tion of Na+channels by drug compounds also causes QT pro-
longation (10, 15, 16).
In the present study, we investigated the effects of KIOM-
79 on hERG channels expressed in HEK-293 cells. Also, we
tested in rat cardiac myocytes whether the voltage-activated
Na+ current and L-type Ca2+ current are affected by KIOM-
79. Finally, the effects of KIOM-79 on the action potential
of rabbit Purkinje fiber were examined and compared with
the result of computational simulation of cardiac action poten-
tial that reflects the changes of ion channel currents observed
in whole-cell patch clamp studies.
MATERIALS AND METHODS
Recording of action potentials 
New Zealand White rabbits of either sex were deeply anes-
thetized with sodium pentobarbitone (50-100 mg/kg, i.p.)
for the surgical removal of hearts according to the regulation
of Institutional Animal Care and Use Committee (IACUC).
Purkinje fibers were isolated from the left ventricles of hearts
and mounted in a continuous flow (5 mL/min)-and temper-
ature controlled (37±1℃) chamber superfused with oxy-
genated normal Tyrode’s (NT) solution. The NT solution con-
tained (mM): 143 NaCl, 5.4 KCl, 5 HEPES, 0.33 NaH2PO4,
0.5 MgCl2, 16.6 glucose and 1.8 CaCl2at pH 7.4 with NaOH.
The tissue was stimulated (2 msec duration and 1.5-2 V am-
plitude) by silver bipolar electrodes at frequency of 1 Hz to
evoke action potentials (APs). APs were recorded using a con-
ventional glass microelectrode with 10-30 M of electrical
resistance when filled with 3 M KCl. APs were recorded using
Axopatch 1D (Axon Instruments, Forster City, CA, U.S.A.),
and data were stored and analyzed using the pClamp 9 (Axon
Instruments). Action potential duration at 50% (APD50) and
90% (APD90) of repolarization, resting membrane potential
(RMP), total amplitude (TA) of maximum depolarization
from RMP, and rate of maximum depolarization at phase 0
(Vmax) values were analyzed.
Culture of HEK-293 cells expressing hERG channel
HEK293 cells stably expressing the hERG channel, a kind
gift from Dr. C. January (17), were cultured in minimum essen-
tial medium (MEM) supplemented with 10% fetal bovine
serum, 1 mM sodium pyruvate, 0.1 mM nonessential amino
acid solution, 100 U/mL penicillin-streptomycin, 100 μ g/
mL streptomycin sulfate, and 100 μ g/mL zeocin in an atmo-
sphere of 95% air and 5% CO2. At 60-80% confluence, cells
were treated with media containing 0.25% trypsin and 0.02%
EDTA for 3 min, washed with fresh media, and dispensed
to new plastic culture dishes. For electrophysiological record-
ing, cells were trypsinized (30 sec) and moved to recording
chamber. 
Isolation of rat ventricular myocytes
Young male Sprague-Dawley rats (3 week old) were anes-
thetized with pentobarbitone sodium (i.p. 200 mg/kg) and
injected with heparin (100 U/kg) at the same time. The heart
was quickly removed and perfused quickly via the aorta onto
a Langendorf retrograde perfusion apparatus. Hearts were
initially perfused with NT solution (50 mL), and then per-
fused with a nominally Ca2+free Tyrode solution (50 mL) con-
taining 0.5 mg/mL of collagenase (Type II, Worthington,
U.K.) for 15 min. Finally, this enzyme containing solution
was washed out by rinsing with high K+, low Cl
-storage solu-
tion (KB solution) for 5 min. the heart was removed from the
Langendorf perfusion apparatus. The ventricular tissues were
then agitated and the single cardiac myocytes were isolated
and stored in the KB solution at 4℃ until used in experi-
ments. 
Whole-cell patch clamp
The isolated cells were transferred to a small chamber (0.2
mL) on the stage of an inverted microscope (IX-70, Olym-
pus) and perfused continuously with NT solution at a rate
of 10 mL/min. A glass microelectrode with a resistance of
2-2.5 MOhm was used to obtain a gigaohm seal. The con-
ventional whole cell patch clamp technique was used to hold
the membrane potential at -60 mV with a patch-clamp am-
plifier (EPC-9, HEKA elektronik, Germany). For each cell,
the capacitance of plasma membrane was automatically ana-
lyzed by EPC-9 and used for the normalization of membrane
currents. The data were filtered at 5 kHz and displayed on a
computer monitor. The data was analysed using Origin (ver.
7.0, Microcal Software, Northampton, MA, U.S.A.). The
high-K+, low-Cl
- storage solution had the following com-
position (in mM): 70 KOH, 50 L-glutamic acid, 55 KCl,
20 taurine, 20 KH2PO4, 3 MgCl2, 10 glucose, 10 HEPES,
0.5 EGTA at pH 7.3 adjusted with KOH. The pipette solu-
404 S.J. Park, K.S. Choi, D.H. Shin, et al.tion for recording K+ current contained (mM): 100 K
- aspar-
tate, 25 KCl, 5 NaCl, 10 HEPES, 1 MgCl2, 4 Mg-ATP and
10 1,2-bis(o-aminophenoxy)ethane-N,N,N’,N’-tetraacetic
acid (BAPTA) at pH 7.2 adjusted with KOH. The pipette
solution for recording Ca2+ and Na+ currents (Cs-aspartate
internal solution) contained (in mM): 90 Cs-aspartate, 20
CsCl, 2 MgCl2, 5 Mg-ATP, 10 HEPES, 2.5 Na2-creatine
phosphate, 10 tetraethyl-ammonium chloride (TEA-Cl), 5
Cs-EGTA with pH 7.3 adjusted with CsOH. NT solution
was used as the extracellular solution perfusing the experi-
mental bath.
Drugs and chemicals
Preparation of KIOM-79; cortex of Magnolia officinalis Rehd.
et Wils., radix of Pueraria lobata Ohwi, radix of Glycyrrhiza
uralensis Fisch, and radix of Euphorbia pekinensis Ruprecht were
collected from the Gansu province in China (2003), and iden-
tified by Prof. J.-H. Kim of Division of Life Science of Dae-
jeon University. We deposited all voucher specimens at the
herbarium of Korea Institute of Oriental Medicine (Nos. 1240,
2, 7, and 207, respectively). KIOM-79 was prepared as pre-
viously described (7). Briefly, equal amounts of gingered Mag-
noliae cortex, parched Puerariae radix, Glycyrrhizae radix,
and Euphoriae Radix were mixed, pulverized, extracted in
80% EtOH and lyophilized. The 80% EtOH extract was
suspended in H2O (2 L) and successively extracted with n-
hexane (×3), EtOAc (×3), and n-BuOH (×3) to give n-
hexane, ethyl acetate, n-BuOH, and water fractions (174 g),
respectively. For experiments, the lyophilized KIOM-79 and
its subfractions were dissolved in dimethylsulfoxide (DMSO,
10 mg/mL) with sonication (30 min), and this was used as
stock solution. All the other chemicals were purchased from
Sigma-Aldrich (St. Louis, MO, U.S.A.).
Statistics
The data is presented as the original recordings and bar
graphs of the mean±SEM (for ntested cells or tissues). Paired
or unpaired Student’s t-test was used for the statistical anal-
ysis where appropriate. P value <0.05 was considered signif-
icant.
RESULTS
The representative trace of membrane potential showed
that an application of 10 μ g/mL of KIOM-79 increased the
action potential duration (APD) and slightly decreased the
amplitude of AP (Fig. 1A). The effects of KIOM-79 on APD
were quantified in terms of APD90 and APD50. Also, we mea-
sured the Vmax and TA (see Materials and methods). The summa-
rized results from three rabbits showed that TA and Vmax
were decreased by 10 μ g/mL of KIOM-79. The APD90 was
increased by KIOM-79 while APD50 was not affected (Fig.
1B). The resting membrane potential (RMP) was not signifi-
cantly changed by KIOM-79.
The Vmax and TA are generally regarded to reflect the activ-
ity of Na+ current. Therefore, by using the whole-cell patch
clamp technique, we tested the effects of KIOM-79 on the
voltage-gated Na+ current (INa) in rat ventricular myocytes.
To activate INa selectively without evoking voltage-gated Ca2+
current, the holding voltage was clamped at -80 mV and step-
like depolarization to -35 mV was applied. By this protocol,
a fast inward current was recorded that inactivated almost
completely within 10 msec. The activation voltage and kinet-
ics were corresponding with the known properties of voltage-
gated Na+ current (18). An application of KIOM-79 (10 μ g/
mL) partially reduced the Na+ current to 75% of control
(Fig. 2).
When the membrane voltage was held at -50 mV, where
most of Na+ channels are inactivated, the step-like depolar-
izations above -40 mV activated inward currents with rela-
tively slow kinetics of activation and inactivation. The cur-
rent to voltage relation (I-V curve) of the peak inward cur-
rents at various test voltages showed an inverted bell-shape
(Fig. 3). These properties correspond with the known char-
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Fig. 1. Effect of KIOM-79 on the APs in rabbit cardiac purkinje fi-
bers. (A) Representative recording of triggered APs in control and
in the presence of 10 μ g/mL KIOM-79 (red trace). (B) Bar graphs
showing shortened total amplitude (TA) and rate of maximum depo-
larization at phase 0 (Vmax) in the presence of 10 μ g/mL KIOM-79
(upper panel). APD90 was increased by KIOM-79 (10 μ g/mL) while
APD50 was not affected (lower panels). *P value <0.05. 
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KIOM-79, 10 μ g/mLacteristics of L-type Ca2+ channels (ICaL) in cardiac myocytes
(18). The application of KIOM-79 (10 μ g/mL) also decreased
the amplitudes of Ca2+ current (ICa) by about 20% (Fig. 3).
The increase of APD90, i.e. delayed repolarization, in AP
recordings suggested that K+ channels might have been inhib-
ited by KIOM-79. Since the cardiac action potential of rab-
bit is relatively short (200-250 msec), IKr is the predominant
player for repolarization (13, 14). To get precise quantitative
evaluation of IKr, we tested the effects of KIOM-79 on hERG
channels expressed in HEK293 cells. In the whole-cell patch
clamp recording with K+ pipette solution, the membrane
voltage was depolarized from -80 to 20 mV (1 sec) and then
repolarized to -50 mV (1 sec). Fig. 4A shows an example of
representative current traces both under control conditions
and after exposure to 10 μ g/mL KIOM-79. The depolariz-
ing step pulse (20 mV) activated a time-dependent outward
current (Idepol) that was increased by KIOM-79. However, the
increasing effect on Idepol was significant only at relatively low
concentration of KIOM-79 (Fig. 4B). During the repolariza-
tion phase (-50 mV), a transient outward current larger than
Idepol was measured, and the peak amplitude of this ‘tail cur-
rent’ (Itail) was decreased by KIOM-79. Fig. 4B shows a dose-
dependent effect of KIOM-79 (0.01-100 μ g/mL) on Idepol and
Itail. With 10 μ g/mL of KIOM-79, the decrease of Itail was only
partial (70%), and this was not different from the decrease
induced by 100 μ g/mL of KIOM-79. The increasing effect on
Idepol was statistically significant only at 1 μ g/mL (paired t-test). 
We also examined the effects of KIOM-79 on hERG cur-
rent at different voltages. The amplitude of Idepol was normal-
ized to the membrane area (pA/pF). The current-voltage rela-
tion (I/V curve) of Idepol showed a bell-shape, a well-known
property of hERG (Fig. 4C). The averaged I-V curve for Idepol
obtained at 10 μ g/mL of KIOM-79 is also plotted in Fig. 4C.
The increase of Idepol by KIOM-79 was observed throughout
the test voltages from above -10 mV. The mean amplitudes
of normalized Itail (pA/pF) measured at the common repolar-
ization voltage (-50 mV) after various levels of depolarizing
voltages were plotted in Fig. 4D. The I-V curve of Itail shows
a voltage-dependent activation of hERG channels that reached
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Fig. 2. Effect of KIOM-79 on voltage-gated Na
+ current (INa) in rat
ventricular myocytes. (A) A representative trace of membrane cur-
rents in rat ventricular myocytes obtained with Cs
+ pipette solution.
A transient INa was activated with a test depolarization (-35 mV)
from holding potential of -80 mV. The INa was decrease by 10 μ g/
mL KIOM-79 (arrow). (B) Summary of the effects of KIOM-79 on
the peak amplitude of INa. In each cell, the current amplitudes mea-
sured at the peak of current were normalized to the control ampli-
tude and mean±SEM values were plotted (n=6). *P value <0.05. 
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Fig. 3. Effect of KIOM-79 on voltage-gated L-type Ca
2+ current (ICaL) in rat ventricular myocytes. (A) The inward currents were recorded in
rat ventricular myocytes with the Cs
+ pipette solution. A representative current obtained by depolarizing pulse from -50 to 0 mV (200
msec) is shown. KIOM-79 (10 μ g/mL) slightly decreased the inward current. (B) To obtain the I-V curve of ICaL, the membrane voltage was
held at -50 mV and incremental step-like pulses were from -40 to 40 mV (10 mV intervals, 200 msec duration). The amplitudes of I-V
curves were decreased by 10 μ g/mL KIOM-79. Each symbol represents mean±SEM of current amplitudes normalized to the cell capaci-
tance (pA/pF, n=5). *P value <0.05. 
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79 (10 μ g/mL) was observed from above 0 mV.
Because KIOM-79 seemed to have multiple effects on hERG
current, we further tested the effects of KIOM-79 fractions
divided by their polarity; water soluble fraction, butanol frac-
tion, ethylacetate fraction, and hexane fraction. The water
fraction showed no effect on hERG current (Fig. 5A) whereas
the butanol and hexane fraction exerted both Idepol increase
and Itail decrease (Fig. 5B, D). Interestingly, the ethylacetate
fraction selectively increased the Idepol without affecting the
amplitude of Itail (Fig. 5C).
As a whole, the decreased Itail of hERG was consistent with
the increase of APD90, and the decrease of INa and ICaL could
explain the decrease of Vmax and TA by KIOM-79. Howev-
er, it was not clear whether the increase of Idepol amplitude in
hERG by KIOM-79 has affected the shape of AP. Also, the
quantitative correlation between changes of individual cur-
rent system and the overall effects on AP are not clear. To get
a speculation on this question, we exploited a computerized
electrophysiology model of rabbit ventricular myocytes. 
The computer simulation model used in this study is
mostly based on Kyoto model (19). Since the Kyoto model
was originally constructed based on the data from guinea-pig
ventricle, we modified the model to fit the experimental data
from rabbit ventricle. This model contains many kinds of
ion channel including hERG (IKr), Na+ channel (INa) and Ca2+
channel (ICaL). The mathematical representative of hERG is
as follows.
IhERG=GhERG∙Cm∙(Vm-EK) ∙ (0.1∙ m1+0.9∙ m2) ∙ h
GhERG=0.3024 ∙(Ko/5.4)0.2
Cm=132 pF, Ko=142 mM
α m1=1/{20∙exp(-Vm/11.5)+5.0 ∙exp(-Vm/300)}
β m1=1/{160∙exp(Vm/28.0)+200∙exp(Vm/1,000.0))+1/
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Fig. 4. Effects of KIOM-79 on hERG current. (A) Representative hERG current traces recorded from HEK293 cells before and after appli-
cation of 10 μ g/mL KIOM-79. The currents were recorded with a test depolarization from the holding potential of -80 to +20 mV (1 sec), with
tail currents recorded upon repolarization to -50 mV for 1 sec. (B) Dose dependent relationship for the increase of Idepol (    ) and the decrease
of Itail (    ) by KIOM-79 (μ g/mL): 0.1 (n=3), 1 (n=8), 10 (n=10), 100 (n=5). Each symbol represents mean±SEM of current amplitudes nor-
malized to control currents (%). The amplitudes of Idepol and Itail were measured at the timing indicated by downward arrows in the pulse
protocol of panel (A). (C, D) I-V curves for Idepol and Itail before and after application of 10 μ g/mL KIOM-79. Each symbol represents mean
±SEM of current amplitudes normalized to the cell capacitance (pA/pF, n=6). *P value <0.05 vs. control. 
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Fig. 5. Effects of the three different fractions of KIOM-79 on hERG current. Left panels; representative current traces obtained by step like
pulses same as Fig. 4A. Right panels; dose dependent relationships for Idepol (closed circle) and Itail (open circle). (A) No significant effect
of the water extract (n=6). (B) Effects of butanol (BuOH) fraction demonstrating the increase of Idepol and the decrease of Itail (n=5). (C) Effects
of ethylacetate (EtOAC) fraction demonstrating the increase of Idepol while no effect on Itail (n=6). (D) Effects of hexane fraction demonstrat-
ing the increase of Idepol and the decrease of Itail (n=6). Each symbol represents mean±SEM of current amplitudes normalized to control
currents (%). *P value <0.05 vs. control. 
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*(2500 ∙exp(Vm/20)}
α m2=1/{1,333∙exp(-Vm/13)+133.3 ∙exp(-Vm/300)}
β m2=1/{10,666∙exp(Vm/28)+13,333 ∙exp(Vm/1,000))+1/
(10,000 ∙exp(Vm/20)}
α h=3.5/{5.6 ∙exp(Vm/15)+2.4∙exp(Vm/300)}
β h=1/{0.067∙exp(-Vm/15)+0.63 ∙exp(-Vm/150)}
Among the parameters describing the kinetics of hERG
activation and inactivation, a modification of parameters relat-
ed to inactivation was crucial to the reproducing the effects
of KIOM-79 on hERG current. To mimic the changes of
recorded hERG current by KIOM-79, we shifted the volt-
age-dependence of opening and closing rate constants relat-
ed with the inactivation process to the right by 10 mV and
to the left by 30 mV, respectively. By this, the voltage-depen-
dence of steady-state inactivation was reduced (Fig. 6A), and
the dual effects of KIOM-79 on Idepol at 20 mV and on Itail at
-50 mV were reproduced (Fig. 6B) similar with the record-
ings shown in Fig. 4A. 
As we applied these changes in parameters (i.e. the shift
of voltage-dependence of opening and closing rate constants
of hERG) to the computational model of AP, it was found
that APD90 was prolonged similar to the recording of APs
(Fig. 7A). In Fig. 7A, the peak amplitude of AP and Vmax were
also slightly decreased because the conductance of Na+ cur-
rent was decreased by 25% reflecting the recorded decrease
of INa. In the simulated result of Fig. 7A, however, the slight
decrease of plateau level shown in Fig. 1A was not reproduced.
The disparity was further resolved by considering the effect
of KIOM-79 on the amplitude of ICaL. As we additionally
reduced the conductance of ICaL to 85% of control, the plateau
of reconstituted AP (Fig. 7B) was found to be lowered simi-
lar to that shown in Fig. 1A. The degree of prolongation in
APD, however, became slightly smaller than the simulated
result in Fig. 7A.
DISCUSSION
In cardiac APs, the key players of phase 3 repolarization
are IKr (rapid delayed rectifier K+current) and IKs (slow delayed
rectifier K+ current) conducted by hERG/KCNE2 and KC-
NQ/minK, respectively (10, 12, 13). However, in the exper-
imental animals like rabbit, the contribution of IKs seems
minor because the durations of cardiac APs are relatively short
(200-250 ms). 
The initial aim of this study was to evaluate the risk of
KIOM-79 on cardiac action potential, i.e. drug-induced AP
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order to reduce the slope of the voltage-dependence of steady-state inactivation, the opening and closing rate constants were modified
as follows. α h=1.0/{1.6*exp([Vm-10]/17.0)+0.7*exp([Vm-10]/300.0)}; β h=1.0/{0.067*exp(-[Vm+30]/17.0)+0.63*exp(-[Vm+30]/150.0)}. The volt-
age-dependence of opening rate constant was shifted to the right by 10 mV, while that of closing rate constant was shifted to the left by
30 mV. Note that the voltage-dependence shows a deviation from typical Boltzman distribution since there are two exponential terms in
the equations describing α h and β h. (B) Reconstructed hERG currents from the altered rate constants of inactivation. Altered inactivation
increased the amplitude of membrane current activated by a depolarizing step from -80 mV to +20 mV, whereas it reduced the amplitude
of membrane current activated by a repolarizing step from +20 to -50 mV. 
Fig. 6. Computer simulation of the effects of KIOM-79 on the volt-
age-dependence of hERG channel activity. (A) A proposed change
in voltage-dependence of steady-state inactivation of hERG to
reproduce the effects of KIOM-79 on hERG current in Fig. 4. In
B
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Alengthening. Actually, the decrease of Itail in hERG suggest-
ed such possibility. However, as was found in the AP mea-
surement and also in the computer simulation, the moder-
ate changes of hERG current induced by KIOM-79 is reflect-
ed as only weak changes of AP. Because the change in hERG
amplitude was already saturated at 10 μ g/mL, it is suggest-
ed that the risk of AP lengthening and early afterdepolariza-
tion by KIOM-79 would be relatively low.
The complex effects of KIOM-79 on hERG, i.e. increase
of Idepol and decrease of Itail, were intriguing. Nevertheless,
such complexity was not surprising considering that multi-
ple compounds are likely to be present in this extract. The
test of fractions of KIOM-79 suggested that the dual effects
of KIOM-79 might be partially separated depending on the
differential solubility to organic solvents display similar effects
on hERG. Since the water fraction had no effect, we could
exclude the polysaccharide compounds as the candidate act-
ing on hERG channel. The hexane fraction showed dual effects,
i.e. increased Idepol and decreased Itail, similar with those of
KIOM-79. The butanol fraction also showed the dual effects,
however, the increase of Idepol was significant only at 10 μ g/mL.
The ethylacetate fraction only increased Idepol, and this effect
was quite potent (Pvalue <0.05 at 0.1 μ g/mL). 
Solvent fractionation is a method to separate compounds
based on their relative solubilities in two different immisci-
ble liquids, usually water and an organic solvent. The order of
polarity between the above four fractions is water (1.0) >buta-
nol (0.602) >ethylacetate (0.228) >hexane (0.009). Gener-
ally, therefore, the petroleum ether or n-hexane fraction con-
tains non-polar compounds like lipids, fatty acids, essential
oils, steroids or triterpenoids. The ethyl acetate fraction has
higher portion of polar components than petroleum ether or
n-hexane fraction. The n-BuOH fraction contains polar com-
pounds, mainly glycosides and tannins. Evaporation of the
remaining water layer leaves polar glycosides, sugars, organic
acids as a viscous gum (19, 20). However, separation by sol-
vent partitioning cannot be always performed in a clearcut man-
ner; overlapping of the compounds in successive fractions is
usually found (19, 21). In the present study, the dual effects on
hERG current were commonly observed, although the poten-
cy is different, in butanol and hexane fractions. Such overlap-
ping results might be due to the incomplete separation of
effective components. Otherwise, it might suggest that mul-
tiple compounds exert similar effects on hERG channels.
In the whole-cell patch clamp recordings of isolated car-
diac myocytes, we also found that the peak amplitude of INa
was decreased by KIOM-79. However, due to the huge con-
ductance of Na+ channels when during the upstroke phase
(phase 0) of cardiac AP (reference), a partial decrease of INa
(about 75% of control) induced only a slight decrease of TA
and upstroke velocity (Vmax). The slight decrease of plateau
potential might be due to either the decrease of ICa or the slight
increase of hERG current in its depolarizing phase (Idepol).
The screening of drug molecules for their adverse effects
on cardiac ion channels is demanding but becoming accel-
erated by the development of automated patch clamp sys-
tems (9). Compared with the patch clamp recording, the reli-
able recording of cardiac action potential in the isolated tis-
sues like Purkinje fiber is technically demanding and requires
cumbersome procedure. In this respect, the application of
computerized model of cardiac action potential combined
with patch clamp data might provide an efficient tool to save
the cost of cardiac toxicity screening of drug development
(22, 23). This could be also valid in traditional herbal drugs
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Fig. 7. Computer simulation of the changes in AP shape by altered properties of hERG, INa and ICaL channels. (A) Changes in AP shape by
applying the altered inactivation of hERG (Fig. 6) and the decrease in Na
+-channel density (75% of control) to the computational model.
By this modification, the APD90 of reconstructed action potential was prolonged from 208.7 to 230.7 msec, and the peak amplitude of phase
0 was decreased, similar with the results from Fig. 1. (B) When the conductance of ICaL was reduced (80% of control) in addition to the above
changes in hERG and INa, the plateau potential was also affected reproducing the results from the cardiac Purkinje fiber of rabbits. The
degree of prolongation in APD90 ( APD90 =15.5 ms) was rather small compared with the results ( APD90=22.0 msec) in (A).
Control
hERG change+75% INa
+80% ICaL
200 ms
60 mV
0 mV
-90 mV
Control
hERG change+75% INa
200 ms
60 mV
0 mV
-90 mV
B Awhere numerous effects from multiple compounds are antic-
ipated. In this study, we confirmed satisfactory consistence
of the simulated results from virtual rabbit cardiomyocyte
model combined with patch clamp study and the real con-
ventional electrode recording. Our present results might
imply the potential usefulness of the computational model-
ing in cardiac electrophysiology.
As mentioned above, KIOM-79 is a mixture of extracts
from four herbs; parched Puerariae radix, gingered Magnoli-
ae cortex, Glycyrrhiza radix and Euphorbiae radix. Literature
search shows that puerarin from Puerariae partially inhibits
L-type Ca2+ channels and cardiac Na+ current (25, 26), which
might explain the partial inhibition of ICa and INa by KIOM-
79. Also, magnolol from Magnoliae cortex shows ion channel
regulatory effects on maxi-K+ channel and Ca2+ channels in
smooth muscle and NMDA receptors in neuronal cells (27-
29). However, no previous studies have directly tested these
compounds on cardiac ion channels and APs.
In summary, in this study, we examined the effect of KIOM-
79 on cardiac ion channels that play critical roles in determin-
ing the parameters of APs. Partial inhibitory effects on hERG
current and INa induced increase of APD90 and decrease of
Vmax, respectively. However, such changes are relatively minute
and do not cause afterdepolarization. Because less than 1 μ g/
mL of KIOM-79 can effectively inhibit VEGF expression
and MAPK activity (8), only a moderate change of cardiac
AP by 10 μ g/mL of KIOM-79 suggests relative safety in terms
of the drug-induced long QT syndrome in cardiac electro-
physiology.
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